Botanix signs a supply agreement with Purisys

/in , /by

Botanix Pharmaceuticals has entered into a supply agreement with Purisys. Purisys has one of the industry’s longest track records and a wide range of offerings in the cannabinoid space. It currently produces all major cannabinoids relevant to pharmaceutical and consumer products. Since 2016, Purisys has also manufactured pharmaceutical-grade cannabidiol at commercial scale utilising a patented process.

Click HERE to read the article on The Market Herald.

Pharma giants to unveil major $1 billion venture to push novel antibiotics

/in , /by

Amid escalating concerns over antibiotic resistance, several big drug makers are creating a new $1 billion for-profit venture to acquire or invest in small antibiotic companies and their nascent products, according to two people familiar with the plans.

Click HERE to see the article on STAT.